Amgen cuts price of cholesterol drug Repatha by 60 percent

Amgen Inc, looking to boost use of its potent cholesterol drug Repatha, has cut the medication's U.S. list price by 60 percent to $5,850, the U.S. biotechnology company said on Wednesday.

from Reuters: Health https://ift.tt/2ONgGx6
via IFTTT

• Tweet
• Share
• Share
• Share
• Share